IMRT

SABR for peripheral lung tumors

• ESMO Clinical Practice Guidelines 2013: SABR is the non surgical treatment of choice (dose to a biologically equivalent tumor dose > 100 Gy)

• NCCN guidelines (version 3.2014): non surgical treatment of choice